Amyl Therapeutics SRL

BiotechnologySeries ALiege, Belgiumamyltx.com

Latest round

Series A

Last raised

Sep 2026

Total raised

$14M

Investors

7

About Amyl Therapeutics SRL

Based in Liege, Belgium and founded in 2020, Amyl Therapeutics SRL operates as a biotechnology company that develops novel therapies that helps treat patients with amyloidosis diseases. The company was co-founded by Pierre Vandepapeliere (CEO & CMO) and Florent Gros. Amyl Therapeutics provides a technology platform named ClariTY that focuses on treating rare and severe protein misfolding diseases. The company also uses a novel mechanism that focuses on antibody light chain (AL) or transthyretin (TTR).

Who invested in Amyl Therapeutics SRL

7 investors across 3 rounds

See all investors in Amyl Therapeutics SRL

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 1, 2026

    Amount

    $4.5M

    Investors

    Locked

  2. Series A

    Nov 2, 2023

    Amount

    $5.4M

    Investors

    Locked

  3. Series A

    Apr 9, 2021

    Amount

    $4.3M

    Investors

    Locked

Questions about Amyl Therapeutics SRL

Who invested in Amyl Therapeutics SRL?

Amyl Therapeutics SRL has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Amyl Therapeutics SRL raised?

Amyl Therapeutics SRL has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Amyl Therapeutics SRL last raise money?

Amyl Therapeutics SRL's most recent round on record is a Series A, in Sep 2026.

What does Amyl Therapeutics SRL do?

Based in Liege, Belgium and founded in 2020, Amyl Therapeutics SRL operates as a biotechnology company that develops novel therapies that helps treat patients with amyloidosis diseases.

Where is Amyl Therapeutics SRL headquartered?

Amyl Therapeutics SRL is headquartered in Liege, Belgium.

Which VCs invest in companies like Amyl Therapeutics SRL?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Amyl Therapeutics SRL's stage. Their profiles are linked below.

Raising like Amyl Therapeutics SRL? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.